当前位置：
X-MOL 学术
›
Eur. J. Heart Fail.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2021-11-03 , DOI: 10.1002/ejhf.2375 Matthew W Segar 1, 2 , Muhammad Shahzeb Khan 3 , Kershaw V Patel 4 , Muthiah Vaduganathan 5 , Vaishnavi Kannan 6 , Duwayne Willett 1, 6 , Eric Peterson 1 , W H Wilson Tang 7 , Javed Butler 3 , Brendan M Everett 5 , Gregg C Fonarow 8 , Thomas J Wang 1 , Darren K McGuire 1 , Ambarish Pandey 1
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2021-11-03 , DOI: 10.1002/ejhf.2375 Matthew W Segar 1, 2 , Muhammad Shahzeb Khan 3 , Kershaw V Patel 4 , Muthiah Vaduganathan 5 , Vaishnavi Kannan 6 , Duwayne Willett 1, 6 , Eric Peterson 1 , W H Wilson Tang 7 , Javed Butler 3 , Brendan M Everett 5 , Gregg C Fonarow 8 , Thomas J Wang 1 , Darren K McGuire 1 , Ambarish Pandey 1
Affiliation
To evaluate the performance of the WATCH-DM risk score, a clinical risk score for heart failure (HF), in patients with dysglycaemia and in combination with natriuretic peptides (NPs).
中文翻译：
将利钠肽与临床风险评分相结合来预测血糖异常患者的心力衰竭
评估 WATCH-DM 风险评分（心力衰竭 (HF) 的临床风险评分）在血糖异常患者中的表现以及与利尿钠肽 (NP) 联合使用的效果。
更新日期：2021-11-03
中文翻译：
将利钠肽与临床风险评分相结合来预测血糖异常患者的心力衰竭
评估 WATCH-DM 风险评分（心力衰竭 (HF) 的临床风险评分）在血糖异常患者中的表现以及与利尿钠肽 (NP) 联合使用的效果。
京公网安备 11010802027423号